Navigation Links
Impaired energy metabolism linked with initiation of plaques in Alzheimer's brain
Date:12/24/2008

Scientists have identified an initiating molecular mechanism in sporadic Alzheimer's disease (AD). The study, published by Cell Press in the December 26th issue of the journal Neuron, provides new information about generation of damaging amyloid β (Aβ) plaques within the AD brain and underscores the importance of developing new preventative and disease-modifying therapies for AD, especially those aimed at interrupting pathological Aβ-production.

AD, the leading cause of dementia in the elderly, is a devastating neurological disorder characterized by accumulation and deposition of sticky clumps of A? protein. A? protein is generated from amyloid precursor protein (APP) by ?-site APP cleaving enzyme (BACE1). Previous research has suggested that BACE1 activity may play a key role in the initiation of AD pathogenesis and identified BACE1 as a promising target for AD therapeutics.

Recently, BACE1 was linked to cellular stress responses in the brain. Importantly, the AD brain exhibits impaired energy metabolism (a stressful situation) and it has been suggested that diminished cerebral use of glucose and oxygen may be an early event in AD pathogenesis.

Senior study author Dr. Robert Vassar from Northwestern University Feinberg School of Medicine has explored the link between energy inhibition and AD pathogenesis. "We have shown previously, using a pharmacological model of energy metabolism inhibition in pre-plaque transgenic mice with an excess of APP, that BACE1 and Aβ levels are elevated in the brain," says Dr. Vassar.

Dr. Vassar and colleagues expanded on their previous work by using glucose deprivation to examine the molecular mechanisms underlying elevated BACE1 levels in response to energy inhibition. They found that glucose deprivation caused an increase in BACE1 levels and led to the phosphorylation of the stress-inducible translation initiation factor, eIF2?. Further, direct phosphorylation of e
'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Scientists identify cell changes leading to impaired artificial kidney function
2. Telescope embedded in glasses lens promises to make driving easier for visually impaired
3. New research program for energy innovations
4. Turning over a new leaf for future energy supplies
5. World Energy Outlook to be presented at Rice University Dec. 9
6. New publishing partnership for Energy for Sustainable Development
7. Fish technology draws renewable energy from slow water currents
8. A model to measure soil health in the era of bioenergy
9. Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group
10. Scientific community called upon to resolve debate on net energy once and for all
11. Trustee makes donation to start new solar energy research center at Rensselaer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... you ever thought the stress of seeing your extend...bad news: a new research report in the December 20...y ( http://www.jleukbio.org ) shows that you migh... same study might lead to entirely new treatments ...hritis, and eczema under control. That,s because r...
(Date:11/26/2009)...ized for their impressive antlers, red deer have b... But a deer,s antlers are much more than decorativ...er when duelling. John Currey, from The University... properties of bone for over half a century and ha...f antler through a long-standing collaboration wit...
(Date:11/26/2009)...SA (methicillin-resistant Staphylococcus Aureus )...hilation as low-temperature plasma prototype devic...and unfailing bactericidal cocktails. , Two prot...nt disinfection of healthy skin (e.g. hands and fe...can pose a lethal threat; and another to shoot bac...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Existing Drug May Lead to ALS Treatment 59797 1Existing Drug May Lead to ALS Treatment 59797 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 1Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6
...be looking at you, but are they really paying atte...ttention, without moving their eyes" Dr. Brian Co...versity of Western Ontario in London, Canada has f... His research Neuromuscular consequences of refle...ine Publication of "Nature Neuroscience". , Our ...
...als from a key molecular receptor that normally sw...ad becomes too intense in the presence of stress a...is (NEC), a leading cause of death in premature ne...ciety for Cell Biology 47th annual meeting. , Dav...ens Hospital of Pittsburgh report that neonatal mi...
... and mineralogy are scientific fields that have be...ge and technologies. The boundary of water and roc...w field of nanoparticle science. , Scientists are... 100 nanometers, influence natural and engineered ...ar materials of a larger size. Nanoparticles are i...
Other Biology News:Leading cause of death in 'preemies' might be controlled by resetting a molecular switch 2Between water and rock -- a new science 2Between water and rock -- a new science 3Between water and rock -- a new science 4Between water and rock -- a new science 5
(Date:11/30/2009)...re-USNewswire/ -- The Michael J. Fox Foundation fo... million in total awards to six research teams wor...apies for Parkinson,s disease. The funding was awa... for Parkinson,s Disease program, made possible b...), a neuroscience-based biotechnology company. ,...
(Date:11/30/2009)... -- Dr. Jessica Torrente, Assistant Professor of R...enter in Washington, D.C., demonstrated the integr...GI) in clinical practice as an adjunct imaging mod...the annual meeting of the Radiological Society of ...hibit was to demonstrate how BSGI is used in the c...
(Date:11/30/2009)...in providing smart and efficient software to the p...eg;, evolutionizing work-from-home histopathology ...software used by 8 of the Top 10 Pharmaceutical Co...de’ basis. , Mount ... announced another evolution in the histopathology...
(Date:11/30/2009)...r 30 ApaTech, the rapidly growing,... growing,Biotech/Pharmaceutical/Medical Technology... Fast 500 for EMEA (Europe, Middle East and Africa...mpanies, five-year revenue growth,for which ApaTe... This,achievement places ApaTech 9th overall in th...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4
... (Nasdaq: INSM ), a developer of follow-on biolo... that on Monday, March 23, 2009, NASDAQ issued a n...s requiring a minimum $1 closing bid price and tho...cly held shares (MVPHS). The suspension will rema...e original rules will be reinstated on Monday, Jul...
...all/ - Spectral Diagnostics Inc. (TSX:SDI), a comp...s, today announced that the 29th International Sym... Brussels, Belgium from March 24-27, 2009 will fea...e of Endotoxin", that will include presentations f...esentations will include topics such as defining t...
...all/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX...on of patient enrolment in its U.K. clinical trial...s administration of REOLYSIN(R) in combination wit...d cancers including breast, and head and neck. The... The Royal Marsden NHS Foundation Trust and The In...
Other Biology Technology:Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule 2Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3
Pyrex brand Fernback baffled culture flask from Sigma-Aldrich
... simple and efficient means for isolation of apopt...netic beads (MagBeads). Annexin V is a Ca2+-depend...y for phosphatidylseri The Apoptotic Cell Isolati...solation of apoptotic cells or removal of dead cel...
Xylene Cyanole FF from Sigma-Aldrich
...igned to be a solid, heavy-duty durable orbital sh...ng and vortexing in nature. The VSOS-4 Orbital ...uniform orbital shaking motion (19mm circular) for...ell/tissue culture, hybridization, staining and de...
Biology Products: